Ross Wooddisse
Background and experience
Ross leads ZS’s drug development business in Europe, bringing together the firm’s strategy, technology and data capabilities to help clients address complex, global challenges. Based in London, he advises senior business and technology leaders at major biopharma organizations on accelerating and improving the drug development life cycle, from research and clinical development through safety and regulatory activities.
His work focuses on transforming global biopharma R&D organizations and helping them maximize the value of their pipelines through people change, process optimization, innovative technology and data-driven insights. His expertise includes clinical data strategy, operating model design, large-scale digital transformation and the deployment of next-generation clinical trial, regulatory and safety capabilities.
Ross also has experience in health authority transformation across product licensing, pharmacovigilance and advisory functions. This work has included technology design, process optimization, platform deployment, analytics and change management. He has led combined business and IT teams, developed board-level business cases and contributed to cross-industry working groups focused on regulatory excellence and patient safety.
Education
M.A. (Cantab) in computer science, University of Cambridge